← Leaderboards
Mohamed E. Abazeed
Northwestern University
$4,785,209
Attributed
$4,785,209
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $872.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,785,209 · 2
By mechanism
R37$2,519,682 · 1
U01$2,265,527 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- Michael Guy Poirier$9,805,680
- James Douglas Engel$17,006,737
- Benjamin David Singer$9,234,980
- Marcelo G. Bonini$11,843,749
- Richard B Silverman$24,563,202
Others in their field
Other Emerging Leaders on “Mathematical Model”
- Jacob Ruff · Cornell University$14,750,000
- Elke Arenholz · Cornell University$14,750,000
- Peter John Hunter · University Of Auckland$10,288,658
- Anna Bershteyn · New York University School Of Medicine$9,111,180
- Deanna A Kulpa · Emory University$8,444,989
- Gonzalo Martin Vazquez Prokopec · Emory University$6,397,224
Research focus
Mathematical ModelNovel TherapeuticsMalignant NeoplasmsCellsStandard Of CareResistanceGeneticIn VivoPharmacotherapyProgramsResponseSamplingChemotherapyTumorExperimental StudyGene ExpressionInnovationInvestigationCancer CellPatient Derived Xenograft ModelMutationChemoradiationArchitectureBiological Markers
Grant awards (11)
Cellular plasticity gives rise to phenotypic equilibrium in small cell lung carcinoma$872,275
U01 · FY2025 · CA · contact PI
Cellular plasticity gives rise to phenotypic equilibrium in small cell lung carcinoma$442,470
U01 · FY2024 · CA · contact PI
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer$347,701
R37 · FY2024 · CA · contact PI
Cellular plasticity gives rise to phenotypic equilibrium in small cell lung carcinoma$455,656
U01 · FY2023 · CA · contact PI
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer$358,680
R37 · FY2023 · CA · contact PI
Cellular plasticity gives rise to phenotypic equilibrium in small cell lung carcinoma$495,126
U01 · FY2022 · CA · contact PI
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer$366,000
R37 · FY2022 · CA · contact PI
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer$364,857
R37 · FY2021 · CA · contact PI
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer$361,425
R37 · FY2020 · CA · contact PI
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer$355,019
R37 · FY2019 · CA · contact PI
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer$366,000
R37 · FY2018 · CA · contact PI